Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade
Open Access
- 9 November 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Human Hypertension
- Vol. 21 (1), 20-27
- https://doi.org/10.1038/sj.jhh.1002101
Abstract
Angiotensin II (Ang II) increases adhesion molecules, cytokines and chemokines and exerts a proinflammatory effect on leucocytes, endothelial cells and vascular smooth muscle cells. Acting via the type 1 receptor, Ang II initiates an inflammatory cascade of reduced nicotinamide-adenine dinucleotide phosphate oxidase, reactive oxygen species (ROS) and nuclear factor-κB, which mediates transcription and gene expression and increases adhesion molecules and chemokines. An excess of ROS decreases nitric oxide bioavailability, causes endothelial dysfunction, and promotes atherosclerosis. Moreover, Ang II interrupts the anti-inflammatory effects of insulin. Together, these effects promote a prothrombotic state as well as plaque rupture. Ang II receptor blockers suppress mediators of inflammation, including ROS and C-reactive protein, and they increase expression of inhibitory κB (an inhibitor of nuclear factor-κB). These anti-inflammatory and antioxidative effects, which are probably due in part to unopposed stimulation of the Ang II type 2 receptor, may be beneficial in acute coronary syndromes and may also contribute to the prevention of type II diabetes mellitus, as insulin resistance is mediated by inflammatory processes.Keywords
This publication has 63 references indexed in Scilit:
- Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulinAmerican Journal of Physiology-Endocrinology and Metabolism, 2003
- Endothelial function: From vascular biology to clinical applicationsThe American Journal of Cardiology, 2002
- Mechanisms linking angiotensin II and atherogenesisCurrent Opinion in Lipidology, 2002
- Angiotensin II Activates Nuclear Transcription Factor κB Through AT1and AT2in Vascular Smooth Muscle CellsCirculation Research, 2000
- The role of the AT2 receptor in hypertensionAmerican Journal of Hypertension, 2000
- AT 2 Receptor Stimulation Increases Aortic Cyclic GMP in SHRSP by a Kinin-Dependent MechanismHypertension, 1998
- Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptorNature, 1995
- Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMPAmerican Journal of Physiology-Cell Physiology, 1994
- Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions.Circulation, 1992
- Nitric oxide: an endogenous modulator of leukocyte adhesion.Proceedings of the National Academy of Sciences of the United States of America, 1991